DEA Cancels Plans to Temporarily Add Kratom Opioids to Schedule I Drug List
The Drug Enforcement Administration said it no longer intends to temporarily add the opioids mitragynine and 7-hydroxymitragynine, both found in the increasingly popular drug kratom, to Schedule I of the Controlled Substances Act (here). The agency will now consider public comments, due Dec. 1, and a Food and Drug Administration scheduling recommendation before deciding how to schedule the drug.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(Federal Register 10/13/16)